Choledocholithiasis laboratory findings

Jump to navigation Jump to search

Choledocholithiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Choledocholithiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Choledocholithiasis laboratory findings On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Choledocholithiasis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Choledocholithiasis laboratory findings

CDC on Choledocholithiasis laboratory findings

Choledocholithiasis laboratory findings in the news

Blogs on Choledocholithiasis laboratory findings

Directions to Hospitals Treating Choledocholithiasis

Risk calculators and risk factors for Choledocholithiasis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

The laboratory data may be normal in as many as a thirds of patients with choledocholithiasis, and further evaluation of the Common bile duct is recommended by imaging studies to clarify the diagnosis.

Laboratory Findings

The laboratory data may be normal in as many as a third of patients with choledocholithiasis, and further evaluation of the Common bile duct is recommended by imaging studies to clarify the diagnosis.

  • Elevated serum bilirubin and alkaline phosphatase reflect biliary obstruction, but these are neither highly sensitive nor specific for CBD stones.
  • High Gamma-glutamyl transferase (GGT) level, greater than 90 U/L, has been suggested to be the most sensitive and specific indicator of CBD stones indicate a high risk of choledocholithiasis.

References

Template:WH Template:WS